XML 44 R33.htm IDEA: XBRL DOCUMENT
v3.25.3

Fair Value Measurements (Tables) | 9 Months Ended
--- | ---
Sep. 30, 2025
Fair Value Disclosures [Abstract] |
Schedule of liabilities measured at fair value on the condensed consolidated balance sheet | The following are the liabilities measured at fair value on the condensed consolidated balance sheet at September 30, 2025 and December 31, 2024 using quoted price in active markets for identical assets (Level 1); significant other observable inputs (Level 2); and significant unobservable inputs (Level 3):
| Level 1: Quoted Prices in Active Markets for Identical Assets |  | Level 2: Significant Other Observable Inputs |  | Level 3: Significant Unobservable Inputs |  | Total at September 30, 2025 |  | Total Gains (Losses) For The Three Months Ended September 30, 2025 |  | Total Gains (Losses) For The Nine Months Ended September 30, 2025 |
Recurring fair value measurements |  |  |  |  |  |  |  |  |  |  |  |
2024 February Institutional/Accredited Investor warrants | $ | — |  |  | $ | — |  |  | $ | 620 |  |  | $ | 620 |  |  | $ | 91,092 |  |  | $ | 290,946 |  |
2024 October Institutional/Accredited Investor Warrants | $ | — |  |  | $ | — |  |  | $ | 13,989 |  |  | $ | 13,989 |  |  | $ | (7,015) |  |  | $ | 278,245 |  |
Senior Convertible Notes - October 2024 | $ | — |  |  | $ | — |  |  | $ | 33,623 |  |  | $ | 33,623 |  |  | $ | (4,623) |  |  | $ | (123,384) |  |
Additional Investment Rights - October 2024 | $ | — |  |  | $ | — |  |  | $ | 111,107 |  |  | $ | 111,107 |  |  | $ | (100,774) |  |  | $ | (105,157) |  |
2024 December Institutional/Accredited Investor Warrants | $ | — |  |  | $ | — |  |  | $ | 81 |  |  | $ | 81 |  |  | $ | 48,627 |  |  | $ | 109,256 |  |
2025 March Institutional/Accredited Investor Warrants | $ | — |  |  | $ | — |  |  | $ | 53,587 |  |  | $ | 53,587 |  |  | $ | (17,330) |  |  | $ | 52,957 |  |
2025 April Institutional/Accredited Investor Warrants | $ | — |  |  | $ | — |  |  | $ | 40,638 |  |  | $ | 40,638 |  |  | $ | (8,955) |  |  | $ | (8,955) |  |
2025 May Institutional/Accredited Investor Warrants | $ | — |  |  | $ | — |  |  | $ | 188,467 |  |  | $ | 188,467 |  |  | $ | (48,550) |  |  | $ | (48,550) |  |
Senior Convertible Notes - May 2025 | $ | — |  |  | $ | — |  |  | $ | 895,497 |  |  | $ | 895,497 |  |  | $ | 167,878 |  |  | $ | 167,878 |  |
2025 September Institutional/Accredited Investor Warrants | $ | — |  |  | $ | — |  |  | $ | 965 |  |  | $ | 965 |  |  | $ | — |  |  | $ | — |  |
Senior Convertible Notes - September 2025 | $ | — |  |  | $ | — |  |  | $ | 100,926 |  |  | $ | 100,926 |  |  | $ | — |  |  | $ | — |  |
Total recurring fair value measurements | $ | — |  |  | $ | — |  |  | $ | 1,439,500 |  |  | $ | 1,439,500 |  |  | $ | 120,350 |  |  | $ | 613,236 |  |
| Level 1: Quoted Prices in Active Markets for Identical Assets |  | Level 2: Significant Other Observable Inputs |  | Level 3: Significant Unobservable Inputs |  | Total at December 31, 2024 |  | Total Gains (Losses) For The Three Months Ended September 30, 2024 |  | Total Gains (Losses) For The Nine Months Ended September 30, 2024
Recurring fair value measurements |  |  |  |  |  |  |  |  |  |  |
2022 July Institutional/Accredited Investor Warrants | $ | — |  |  | $ | — |  |  | $ | — |  |  | $ | — |  |  | $ | — |  |  | 4,621 |
Private warrants - July 2024 | $ | — |  |  | $ | — |  |  | $ | — |  |  | $ | — |  |  | $ | 80,673 |  |  | $ | 80,673 |
2024 February Institutional/Accredited Investor warrants | $ | — |  |  | $ | — |  |  | $ | 291,566 |  |  | $ | 291,566 |  |  | $ | 728,663 |  |  | 3,036,476 |
2024 October Institutional/Accredited Investor Warrants | $ | — |  |  | $ | — |  |  | $ | 292,234 |  |  | $ | 292,234 |  |  | $ | — |  |  | $ | — |
Senior Convertible Notes - October 2024 | $ | — |  |  | $ | — |  |  | $ | 2,475,162 |  |  | $ | 2,475,162 |  |  | $ | — |  |  | — |
Additional Investment Rights - October 2024 | $ | — |  |  | $ | — |  |  | $ | 5,950 |  |  | $ | 5,950 |  |  | $ | — |  |  | $ | — |
2024 December Institutional/Accredited Investor Warrants | $ | — |  |  | $ | — |  |  | $ | 109,337 |  |  | $ | 109,337 |  |  | $ | — |  |  | — |
Derivative liability - non-controlling redeemable preferred shares | $ | — |  |  | $ | — |  |  | $ | — |  |  | $ | — |  |  | $ | — |  |  | $ | (3,626) |
Total recurring fair value measurements | $ | — |  |  | $ | — |  |  | $ | 3,174,249 |  |  | $ | 3,174,249 |  |  | $ | 809,336 |  |  | $ | 3,118,144 |
Schedule of fair value on a recurring basis | The following is a reconciliation of the opening and closing balances for the liabilities related to the warrants (Note 11) and derivative liability - non-controlling redeemable preferred shares measured at fair value on a recurring basis using significant unobservable inputs (Level 3) during the three and nine months ended September 30, 2025:
|  |  | 2024 February Institutional/Accredited Investor warrants |  | 2024 October Institutional/Accredited Investor Warrants |  | Senior Convertible Notes - October 2024 |  | Additional Investment Rights - October 2024 |  | 2024 December Institutional/Accredited Investor Warrants |  | 2025 March Institutional/Accredited Investor Warrants |  | Senior Convertible Notes - March 2025 |  | 2025 April Institutional/Accredited Investor Warrants |  |  |  | 2025 May Institutional/Accredited Investor Warrants |  | Senior Convertible Notes - May 2025 |  | 2025 September Institutional/Accredited Investor Warrants |  | Senior Convertible Notes - September 2025 |  |  |  |
Balance at December 31, 2024 |  |  | $ | 291,566 |  |  | $ | 292,234 |  |  | $ | 2,475,162 |  |  | $ | 5,950 |  |  | $ | 109,337 |  |  | $ | — |  |  | $ | — |  |  | $ | — |  |  |  |  | $ | — |  |  | $ | — |  |  | $ | — |  |  | $ | — |  |  |  |  |
Initial fair value |  |  | — |  |  | — |  |  | — |  |  | — |  |  | — |  |  | 106,544 |  |  | 1,393,456 |  |  | — |  |  |  |  | — |  |  | — |  |  | — |  |  | — |  |  |  |  |
Conversion of Convertible Notes |  |  | — |  |  | — |  |  | (3,058,031) |  |  | — |  |  | — |  |  | — |  |  | — |  |  | — |  |  |  |  | — |  |  | — |  |  | — |  |  | — |  |  |  |  |
Total (gains) losses for period included in earnings |  |  | (217,896) |  |  | (265,178) |  |  | 1,091,006 |  |  | 676,717 |  |  | (69,025) |  |  | — |  |  | — |  |  | — |  |  |  |  | — |  |  | — |  |  | — |  |  | — |  |  |  |  |
Balance at March 31, 2025 |  |  | 73,670 |  |  | 27,056 |  |  | 508,137 |  |  | 682,667 |  |  | 40,312 |  |  | 106,544 |  |  | 1,393,456 |  |  | — |  |  |  |  | — |  |  | — |  |  | — |  |  | — |  |  |  |  |
Initial fair value |  |  | — |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 31,683 |  |  |  |  | 139,917 |  |  | 2,135,181 |  |  | — |  |  | — |  |  |  |  |
Conversion of Convertible Notes |  |  | — |  |  | — |  |  | 617,017 |  |  | — |  |  | — |  |  | — |  |  | (1,393,456) |  |  | — |  |  |  |  | — |  |  | — |  |  | — |  |  | — |  |  |  |  |
Total (gains) losses for period included in earnings |  |  | 18,042 |  |  | (20,082) |  |  | (972,245) |  |  | (672,334) |  |  | 8,396 |  |  | (70,287) |  |  | — |  |  | — |  |  |  |  | — |  |  | — |  |  | — |  |  | — |  |  |  |  |
Balance at June 30, 2025 |  |  | 91,712 |  |  | 6,974 |  |  | 152,909 |  |  | 10,333 |  |  | 48,708 |  |  | 36,257 |  |  | — |  |  | 31,683 |  |  |  |  | 139,917 |  |  | 2,135,181 |  |  | — |  |  | — |  |  |  |  |
Initial fair value |  |  | — |  |  | — |  |  | — |  |  | — |  |  | — |  |  | — |  |  | — |  |  | — |  |  |  |  | — |  |  | — |  |  | 965 |  |  | 100,926 |  |  |  |  |
Exercise warrants |  |  | — |  |  | — |  |  | — |  |  | — |  |  | — |  |  | — |  |  | — |  |  | — |  |  |  |  | — |  |  | — |  |  | — |  |  | — |  |  |  |  |
Conversion of Convertible Notes |  |  | — |  |  | — |  |  | (123,909) |  |  | — |  |  | — |  |  | — |  |  | — |  |  | — |  |  |  |  | — |  |  | (1,071,806) |  |  | — |  |  | — |  |  |  |  |
Total (gains) losses for period included in earnings |  |  | (91,092) |  |  | 7,015 |  |  | 4,623 |  |  | 100,774 |  |  | (48,627) |  |  | 17,330 |  |  | — |  |  | 8,955 |  |  |  |  | 48,550 |  |  | (167,878) |  |  | — |  |  | — |  |  |  |  |
Balance at September 30, 2025 |  |  | $ | 620 |  |  | $ | 13,989 |  |  | $ | 33,623 |  |  | $ | 111,107 |  |  | $ | 81 |  |  | $ | 53,587 |  |  | $ | — |  |  | $ | 40,638 |  |  |  |  | $ | 188,467 |  |  | $ | 895,497 |  |  | $ | 965 |  |  | $ | 100,926 |  |  |  |  |
Schedule of carrying values and estimated fair values of debt instruments | The following outstanding debt obligations are reflected in the Company's condensed consolidated balance sheet at carrying value since the Company did not elect to remeasure the debt obligations to fair value at the end of each reporting period. The carrying values of these debt obligations approximate fair value due to the short-term maturity of these debt obligations.
| September 30, 2025 |  | December 31, 2024 |
| Fair Value | Carrying Value |  | Fair Value | Carrying Value |
Term loan | $ | 627,727 |  | $ | 627,727 |  |  | $ | 1,445,345 |  | $ | 1,445,345 |  |
Promissory Notes - August 16, 2024 | $ | 853,841 |  | $ | 853,841 |  |  | $ | 884,676 |  | $ | 884,676 |  |
Promissory Notes - August 27, 2024 | $ | — |  | $ | — |  |  | $ | 516,818 |  | $ | 516,818 |  |
Senior Convertible Notes - December 2024(1) | $ | 30,443 |  | 30,443 |  |  | $ | 250,000 |  | $ | 250,000 |  |
Promissory Notes - Fermata Energy II LLC | $ | 570,616 |  | $ | 570,616 |  |  | $ | — |  | $ | — |  |
__________________ (1) Amount is net of conversions.

X
- Definition Tabular disclosure of assets, including [financial] instruments measured at fair value that are classified in stockholders' equity, if any, by class that are measured at fair value on a recurring basis. The disclosures contemplated herein include the fair value measurements at the reporting date by the level within the fair value hierarchy in which the fair value measurements in their entirety fall, segregating fair value measurements using quoted prices in active markets for identical assets (Level 1), significant other observable inputs (Level 2), and significant unobservable inputs (Level 3). + References Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 820 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Subparagraph (b) -Publisher FASB -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2 Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 820 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Subparagraph (a) -Publisher FASB -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2 + Details
Name: | us-gaap_FairValueAssetsMeasuredOnRecurringBasisTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- References No definition available. + Details
Name: | us-gaap_FairValueDisclosuresAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of information pertaining to carrying amount and estimated fair value of short-term and long-term debt instruments or arrangements, including but not limited to, identification of terms, features, and collateral requirements. + References No definition available. + Details
Name: | us-gaap_ScheduleOfCarryingValuesAndEstimatedFairValuesOfDebtInstrumentsTableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of assets and liabilities, including [financial] instruments measured at fair value that are classified in stockholders' equity, if any, that are measured at fair value on a recurring basis. The disclosures contemplated herein include the fair value measurements at the reporting date by the level within the fair value hierarchy in which the fair value measurements in their entirety fall, segregating fair value measurements using quoted prices in active markets for identical assets (Level 1), significant other observable inputs (Level 2), and significant unobservable inputs (Level 3). + References Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 820 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Subparagraph (b) -Publisher FASB -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2 Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 820 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Subparagraph (a) -Publisher FASB -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2 + Details
Name: | us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration